1. Home
  2. SLXN vs ZONE Comparison

SLXN vs ZONE Comparison

Compare SLXN & ZONE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLXN
  • ZONE
  • Stock Information
  • Founded
  • SLXN 2008
  • ZONE 2022
  • Country
  • SLXN Israel
  • ZONE United States
  • Employees
  • SLXN N/A
  • ZONE N/A
  • Industry
  • SLXN
  • ZONE
  • Sector
  • SLXN
  • ZONE
  • Exchange
  • SLXN NYSE
  • ZONE NYSE
  • Market Cap
  • SLXN 7.3M
  • ZONE 19.3M
  • IPO Year
  • SLXN N/A
  • ZONE 2024
  • Fundamental
  • Price
  • SLXN $0.80
  • ZONE $2.51
  • Analyst Decision
  • SLXN Strong Buy
  • ZONE
  • Analyst Count
  • SLXN 1
  • ZONE 0
  • Target Price
  • SLXN $5.00
  • ZONE N/A
  • AVG Volume (30 Days)
  • SLXN 141.1K
  • ZONE 107.9K
  • Earning Date
  • SLXN 08-21-2025
  • ZONE 05-14-2025
  • Dividend Yield
  • SLXN N/A
  • ZONE N/A
  • EPS Growth
  • SLXN N/A
  • ZONE N/A
  • EPS
  • SLXN N/A
  • ZONE N/A
  • Revenue
  • SLXN N/A
  • ZONE $1,887,046.00
  • Revenue This Year
  • SLXN N/A
  • ZONE N/A
  • Revenue Next Year
  • SLXN N/A
  • ZONE N/A
  • P/E Ratio
  • SLXN N/A
  • ZONE N/A
  • Revenue Growth
  • SLXN N/A
  • ZONE 38.12
  • 52 Week Low
  • SLXN $0.58
  • ZONE $0.81
  • 52 Week High
  • SLXN $41.85
  • ZONE $5.54
  • Technical
  • Relative Strength Index (RSI)
  • SLXN N/A
  • ZONE N/A
  • Support Level
  • SLXN N/A
  • ZONE N/A
  • Resistance Level
  • SLXN N/A
  • ZONE N/A
  • Average True Range (ATR)
  • SLXN 0.00
  • ZONE 0.00
  • MACD
  • SLXN 0.00
  • ZONE 0.00
  • Stochastic Oscillator
  • SLXN 0.00
  • ZONE 0.00

About SLXN BIOMOTION SCIENCES

Silexion Therapeutics Corp a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for KRAS-driven cancers. The KRAS gene is an oncogene that is involved in the regulation of cell division as a result of its ability to relay external signals into the cell. Its product candidate, SIL204, consists of locally administered small interfering RNAs, or siRNA, in a solution, as a first-line treatment of locally advanced pancreatic cancer patients, or LAPC, in combination with standard-of-care chemotherapy. It is currently focused on treatment for pancreatic cancer tumors bearing the KRAS G12D or KRAS G12V mutations where metastases have not been detected and are non-resectable, i.e. it is not able to be surgically removed.

About ZONE CLEANCORE SOLUTIONS INC

CleanCore Solutions Inc engages in the development and manufacturing of cleaning products that produce pure aqueous ozone for professional, industrial, or home use. The firm has a patented nanobubble technology using aqueous ozone that is effective in cleaning, sanitizing, and deodorizing surfaces and high-touch areas. The company offers products and solutions that are marketed for janitorial and sanitation, ice machine cleaning, laundry, and industrial industries. Its products are used in many types of environments including retail establishments, distribution centers, factories, warehouses, restaurants, schools and universities, airports, healthcare, food service, and commercial buildings such as offices, malls, and stores.

Share on Social Networks: